Basics MaxCyte, Inc. Common Stock IPO Date: July 26, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $253.04M Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 3.00% Avg Daily Range (30 D): $0.06 | 2.23% Avg Daily Range (90 D): $0.09 | 2.75% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): .91M Avg Daily Volume (90 D): .68M Trade Size Avg Trade Size (Sh.): 105 Avg Trade Size (Sh.) (30 D): 154 Avg Trade Size (Sh.) (90 D): 123 Institutional Trades Total Inst.Trades: 160 Avg Inst. Trade: $2.32M Avg Inst. Trade (30 D): $.94M Avg Inst. Trade (90 D): $.92M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.23M Avg Closing Trade (30 D): $.82M Avg Closing Trade (90 D): $.78M Avg Closing Volume: 522.51K         News Jul 4, 2024 @ 1:11 PM Global Transfection Technologies Market Predicted ... Source: Polaris Market Research (Pmr) Jun 13, 2024 @ 1:55 PM Does MaxCyte (MXCT) Have the Potential to Rally 85... Source: Zacks Equity Research Jun 13, 2024 @ 12:50 PM Recent Price Trend in MaxCyte (MXCT) is Your Frien... Source: Zacks Equity Research May 29, 2024 @ 12:05 PM MaxCyte to Participate in William Blair 44th Annua... Source: MaxCyte, Inc May 22, 2024 @ 12:05 PM MaxCyte Signs Strategic Platform License Agreement... Source: MaxCyte, Inc Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.4 $-.1 $-.1 Diluted EPS $-.1 Revenue $ 37.68M $ 10.39M $ 8.69M Gross Profit $ 30.48M $ 8.89M $ 6.41M Net Income / Loss $ -41.79M $ -10.26M $ -10.6M Operating Income / Loss $ -51.22M $ -12.3M $ -12.9M Cost of Revenue $ 7.19M $ 1.5M $ 2.28M Net Cash Flow $ 1.14M $ -4.5M $ -9.07M PE Ratio